BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 18976402)

  • 1. CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions.
    Tardío JC
    J Cutan Pathol; 2008 Dec; 35(12):1079-92. PubMed ID: 18976402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD34-reactive tumors of the skin. An updated review of an ever-growing list of lesions.
    Tardío JC
    J Cutan Pathol; 2009 Jan; 36(1):89-102. PubMed ID: 19125742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of smooth muscle myosin, smooth muscle actin, h-caldesmon, and calponin in the diagnosis of myofibroblastic and smooth muscle lesions of skin and soft tissue.
    Perez-Montiel MD; Plaza JA; Dominguez-Malagon H; Suster S
    Am J Dermatopathol; 2006 Apr; 28(2):105-11. PubMed ID: 16625070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous CD34+ spindle cell neoplasms: Histopathologic features distinguish spindle cell lipoma, solitary fibrous tumor, and dermatofibrosarcoma protuberans.
    Wood L; Fountaine TJ; Rosamilia L; Helm KF; Clarke LE
    Am J Dermatopathol; 2010 Dec; 32(8):764-8. PubMed ID: 20559119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Atrophic dermatofibrosarcoma protuberans: an uncommon and misleading variant.
    Wu JK; Malik MM; Egan CA
    Australas J Dermatol; 2004 Aug; 45(3):175-7. PubMed ID: 15250897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular digital fibromas: distinctive CD34-positive lesions that may mimic dermatofibrosarcoma protuberans.
    McNiff JM; Subtil A; Cowper SE; Lazova R; Glusac EJ
    J Cutan Pathol; 2005 Jul; 32(6):413-8. PubMed ID: 15953374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumoral, quasitumoral and pseudotumoral lesions of the superficial and somatic soft tissue: new entities and new variants of old entities recorded during the last 25 years. Part XII: appendix.
    Bisceglia M; Spagnolo D; Galliani C; Fisher C; Suster S; Kazakov DV; Cooper K; Michal M
    Pathologica; 2006 Aug; 98(4):239-98. PubMed ID: 17175794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerosing dermatofibrosarcoma protuberans (DFSP): an unusual variant with focus on the histopathologic differential diagnosis.
    Sabater-Marco V; Pérez-Vallés A; Berzal-Cantalejo F; Rodriguez-Serna M; Martinez-Diaz F; Martorell-Cebollada M
    Int J Dermatol; 2006 Jan; 45(1):59-62. PubMed ID: 16426380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
    Sachdev R; Sundram U
    J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD34 expression in primary cutaneous malignant melanoma: apropos of a case and review of the aberrant melanoma phenotype.
    Breza TS; Magro CM
    J Cutan Pathol; 2005 Nov; 32(10):685-9. PubMed ID: 16293181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myxoid dermatofibrosarcoma protuberans: a rare variant analyzed in a series of 23 cases.
    Reimann JD; Fletcher CD
    Am J Surg Pathol; 2007 Sep; 31(9):1371-7. PubMed ID: 17721193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-evaluation of CD34-negative dermatofibrosarcoma protuberans with a highly sensitive, tyramide-based immunohistochemical analysis.
    Nakanishi G; Suzuki N; Lin SN; Asagoe K; Iwatsuki K
    Eur J Dermatol; 2008; 18(6):719-21. PubMed ID: 19049941
    [No Abstract]   [Full Text] [Related]  

  • 13. [Giant cell fibroblastoma associated with Darier-Ferrand dermatofibrosarcoma in an adult].
    Kourda M; Krichen H; Kennou H; Ben Yahia K; Ben Ayed M; Souissi R
    Ann Dermatol Venereol; 1998 Apr; 125(4):255-6. PubMed ID: 9747262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical markers in fibrohistiocytic lesions: factor XIIIa, CD34, S-100 and p75.
    West KL; Cardona DM; Su Z; Puri PK
    Am J Dermatopathol; 2014 May; 36(5):414-9. PubMed ID: 24162384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein D in CD34-positive and CD34-negative cutaneous neoplasms: a useful marker in differentiating superficial acral fibromyxoma from dermatofibrosarcoma protuberans.
    Lisovsky M; Hoang MP; Dresser KA; Kapur P; Bhawan J; Mahalingam M
    Mod Pathol; 2008 Jan; 21(1):31-8. PubMed ID: 17885669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-grade sarcomas with CD34-positive fibroblasts and low-grade myofibroblastic sarcomas.
    Fisher C
    Ultrastruct Pathol; 2004; 28(5-6):291-305. PubMed ID: 15764578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatofibrosarcoma protuberans and its fibrosarcomatous variant with areas of myoid differentiation: a report of three cases.
    Morimitsu Y; Hisaoka M; Okamoto S; Hashimoto H; Ushijima M
    Histopathology; 1998 Jun; 32(6):547-51. PubMed ID: 9675594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD34+ pigmented fibrous proliferations: the morphologic overlap between pigmented dermatofibromas and Bednar tumors.
    McAllister JC; Recht B; Hoffman TE; Sundram UN
    Am J Dermatopathol; 2008 Oct; 30(5):484-7. PubMed ID: 18806495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermatofibrosarcoma Darier and Ferrand. Immunohistochemistry study of 38 cases. Research on a specific marker].
    Declerck D; Claye C; Rotteleur G; Lecomte-Houcke M
    Ann Pathol; 1997 Oct; 17(5):324-8. PubMed ID: 9471146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pleomorphic hyalinizing angiectasic soft-tissue tumor. Description of a case].
    Gallo C; Murer B; Roncaroli F
    Pathologica; 1997 Oct; 89(5):531-5. PubMed ID: 9489401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.